The polymerase chain reaction (PCR) was investigated for detecting human parvovirus B19 (B19) DNA in sera. Three pairs of oligonucleotides were evaluated as primers. The best oligonucleotide pair spanned 699 nucleotides, including the region common to VP1 and VP2. After PCR amplification of B19 DNA in serum, a 699-nucleotide DNA fragment was detected on agarose gels. This DNA fragment was B19 DNA, because after Southern transfer it hybridized to a 19-nucleotide internal probe and contained a single PstI Human parvovirus B19 (B19) causes several syndromes, including erythema infectiosum, chronic arthritis in adults, aplastic crisis in patients with hemolytic anemias, fetal death, and chronic anemia and neutropenia in immunocompromised patients (2, 3, 7, 10, 15, 17, 20, 22, 25) . The virus replicates only in erythroid precursor cells derived from bone marrow (17, 19) . In vitro culture systems producing human parvovirus B19 have not been developed. Consequently, diagnostic tests for this infection are not widely available. The few laboratories that do these tests must rely on antigen obtained from the serum of infected individuals (4). In addition, we and others have observed chronic B19 infection of immunocompromised patients whose serum lacked immunoglobulin G (IgG) and IgM to the virus (15, 16; W. C. Koch and S. P. Adler, J. Pediatr., in press). Diagnosis was made by detecting B19 DNA in their sera by dot blot analysis. To circumvent these problems in diagnosis and because the polymerase chain reaction (PCR) is sensitive and specific for detecting several other viruses, we evaluated the PCR for the detection of human parvovirus B19 in serum and other body fluids (1, 8, 13, 18, 23 2.0 mM MgCl2; 0.01% gelatin; and 1 to 3 ,ul of sample. After the mixture was heated to 94°C for 3 min, 2.0 U of Taq polymerase (Perkin-Elmer Cetus, Norwalk, Conn.) was added. The mixtures were overlaid with 100 ,ul of mineral oil, and then thermal cycling was carried out in a programmable heat block (Perkin-Elmer). Each cycle consisted of 2 min at 94°C, 2 min at 37°C, and 3 min at 72°C. An additional 7 min was added at the end of the cycling to complete extension of the primers. Thirty-five cycles were performed in 6 h.
Human parvovirus B19 (B19) causes several syndromes, including erythema infectiosum, chronic arthritis in adults, aplastic crisis in patients with hemolytic anemias, fetal death, and chronic anemia and neutropenia in immunocompromised patients (2, 3, 7, 10, 15, 17, 20, 22, 25) . The virus replicates only in erythroid precursor cells derived from bone marrow (17, 19) . In vitro culture systems producing human parvovirus B19 have not been developed. Consequently, diagnostic tests for this infection are not widely available. The few laboratories that do these tests must rely on antigen obtained from the serum of infected individuals (4) . In addition, we and others have observed chronic B19 infection of immunocompromised patients whose serum lacked immunoglobulin G (IgG) and IgM to the virus (15, 16 ; W. C. Koch and S. P. Adler, J. Pediatr., in press). Diagnosis was made by detecting B19 DNA in their sera by dot blot analysis. To circumvent these problems in diagnosis and because the polymerase chain reaction (PCR) is sensitive and specific for detecting several other viruses, we evaluated the PCR for the detection of human parvovirus B19 in serum and other body fluids (1, 8, 13, 18, 23) .
MATERIALS AND METHODS
Selection of sequences for primers and probes. B19 has a single-stranded DNA approximately 5,400 nucleotides long (12) . The B19 genome encodes two capsid proteins, VP1 (84 kilodaltons) and VP2 (58 kilodaltons) and a nonstructural protein (77 kilodaltons) (11) . VP1 and VP2 share common carboxy-terminal amino acids. VP2 composes 96% of the viral capsid. We evaluated three sets of primers and probes: one set located within VP1, one set within the nonstructural gene, and one set within VP2 (Table 1) added to the hybridization solution (6x SSPE, 1% SDS) and incubated overnight at 5°C less than the melting temperature of each probe. After hybridization the membranes were washed in 6x SSPE-1% SDS three times at room temperature and once at hybridization temperature. After washing, the membranes were exposed to Cronex X-ray film (Du Pont) for 3 to 18 h at -70°C with an intensifying screen. Dot blot hybridization. Dot blot hybridization was performed as described by Clewley; plasmid pSP321, which contains the middle one-half (2.7 kilobases) of the B19 genome cloned into the PstI site in the ampicillin resistance gene of pBR322 (9) , was used as a probe. Briefly, 10 pul of sample was added to 200 pul of 2x SSC (0.3 M NaCI, 0.03 M sodium citrate [pH 7.0]), followed by the addition of 200 puI of 1 M NaCl-0.1 M NaOH. After 10 min at room temperature, 1.8 ml of 2x SSC was added and then filtered over a nitrocellulose membrane (Schleicher & Schuell) that had been prewet with 20x SSC for 30 min. The membrane was washed briefly in 2x SSC and baked at 80°C for 2 h in a vacuum oven. The membrane was prehybridized for 4 h at 65°C in 10 ml of hybridization solution (6x SSC, 0.5% SDS, 1x Denhardt solution, 100 ,ug of sheared salmon sperm DNA per ml). The membrane was transferred to fresh hybridization solution with 106 cpm of [32P]dCT-labeled probe (2 x 106 cpm/,ug). The filter was hybridized overnight at 65°C with mixing. After hybridization, the filter was washed at 65°C for 2 to 4 h with serial changes of lx SSC-0.1% SDS, allowed to dry at room temperature for 10 to 20 min, and exposed to X-ray film. Autoradiograms were developed after 3, 18, and 72 h and 7 days at -70°C with an intensifying screen.
pBS321 was labeled with [32P]dCT by nick translation (21) . Unincorporated [32P]dCT was removed, and the plasmid was concentrated with an Centricon 30 filter (W. R. Grace and Co., Danvers, Mass). Before use, the labeled plasmid was added to 0.5 ml of sheared salmon sperm DNA (10 mg/ml), placed in a boiling water bath for 3 min, and then placed on ice for 5 min.
Serologic assays. IgG and IgM to B19 in human sera were detected as previously described (4, 14 Additional B19-positive sera were provided by B. J. Cohen Other specimens included ascites and pericardial fluid from a hydropic fetus and urine and peripheral blood mononuclear cells from a patient with aplastic crisis. Peripheral blood mononuclear cells were obtained from heparinized blood samples by using Sepracell-MN (Sepratech Corp., Oklahoma City, Okla.); 5 ,ul of the cell suspension was used in the PCR assay without prior DNA extraction.
For amplification of sera and other body fluids, 1 to 3 ,ul was added directly to the PCR reaction mixture.
Control serum samples were obtained at random from 20 obstetric patients when blood was drawn for other purposes.
Ail serum was stored at -70°C.
RESULTS
Each of the three primers worked effectively for the detection of B19 DNA (Tables 1 and 4 ). Primers Ki and K2 were selected for complete characterization of the PCR reaction. To find optimal reaction conditions, three annealing temperatures (37, 40, and 42°C) and three different numbers of total cycles (25, 30, and 35) were investigated. The combination of 35 cycles and 37°C produced the best level of sensitivity and specificity. The expected amplified product of 699 base pairs was observed after amplification of a dot-blot-positive serum sample (Fig. 1) . PstI digestion of the 699-base-pair fragment generated by primers Ki and K2 in two serum samples yielded a 194-base-pair fragment and a 505-base-pair fragment, as predicted from the nucleotide sequence (Fig. 1 ). PCR performed with primers K6 and K7 yielded a DNA fragment of the predicted size, 442 base pairs, that lacked a PST1 site (Fig. 1) . None of the primer sets produced B19-specific DNA fragments when either cytomegalovirus DNA, simian virus 40 DNA, or human cellular DNA (from MRC-5 fibroblasts and from lymphocytes) was used.
To determine the sensitivity of PCR, PCR was compared with dot blot hybridization. The serum from a patient with aplastic crisis due to human parvovirus B19 was serially diluted. The dot blot assay detected approximately 0.2 ng of B19 DNA in 10 ,uI of the diluted serum with an exposure of the nitrocellulose filter for 7 days at -70°C (Fig. 2) . In contrast, when 1-pul samples of the same dilutions of this serum were amplified by using PCR and the agarose gels were stained with ethidium bromide, B19 DNA was detected in the 1:107 dilution (Fig. 3A) . When the agarose gel was probed with the internal probe K5, both single-and doublestranded fragments were detected in a 1:1010 dilution of this serum with an exposure at -70°C for 3 h (Fig. 3B) . Therefore, with ethidium bromide staining the PCR detected approximately 0.02 pg of B19 DNA, and with a radiolabeled internal probe the PCR detected 0.02 fg of B19 DNA.
Dot blot hybridization and PCR were compared by using 15 10 ,ul of each dilution was denatured and filtered over nitrocellulose. For the serum the fold dilution is indicated above three of the dots, and for the plasmid the quantity of DNA on each dot is indicated below three of the dots. 32P-labeled pSP321 was the probe, and the nitrocellulose sheet was exposed to X-ray film for 1 week at -70°C.
six patients had at least one serum sample positive for B19 DNA by dot blot hybridization. Of 11 dot-blot-positive serum samples, all were also positive by PCR. Of four serum samples negative by dot blot hybridization, three were positive by PCR. One serum sample was negative by both tests. In addition we assayed 20 serum samples from 20 pregnant women selected randomly. All 20 serum samples lacked IgM to B19, and 8 contained IgG to B19. All 20 serum samples were negative by dot blot hybridization and also negative by PCR.
Twenty-nine serum samples from 18 patients with proven B19 infections were assayed for IgM and IgG to B19 and by PCR (Table 3) Samples (1 ,uI) of the same dilutions of the serum used for dot blot hybridization (Fig. 2) were amplified with primers Ki and K2. After amplification and agarose gel electrophoresis, the gel was stained with ethidium bromide (A). The DNA fragments of this gel were transferred to a nylon membrane and probed with 32P-labeled internal probe K5 (B). Ethidium bromide stained only the doublestranded fragment (B) in serum diluted i0-'. The radiolabeled probe detected single-and double-stranded fragments in serum diluted 10-10 after 3 h of exposure to X-ray film at -70°C.
VOL. 28, 1990 on October 19, 2017 by guest http://jcm.asm.org/ atients) that contained IgM but were PCR negative were obtained during the convalescent phase of illness (.3 days after the onset of symptoms) and contained IgG to B19. Seven serum samples from five patients lacked IgM to B19, and all were PCR positive. One of these five patients was immunocompromised and had an impaired ability to make IgG and IgM to B19 (Koch and Adler, in press). The other four serum samples that lacked IgM but were PCR positive were from four patients with sickle cell disease and aplastic crisis. Each of these four serum samples was obtained during acute infection (<4 days after the onset of symptoms) and lacked IgG to B19. Of 24 serum samples positive by PCR, 20 were positive when only ethidium bromide was used to detect B19 DNA after amplification (Table 3) . Four serum samples were positive only after a radiolabeled probe was used for detection. These four serum samples (from four patients) were obtained during the convalescent phase, and each contained IgG and IgM to B19. Table 4 compares DNA detection by dot blot hybridization and PCR with serologic tests for IgG and IgM to B19 by duration of illness. Of 10 serum samples obtained 3 days or less after the onset of illness, 9 were PCR positive but only 6 were IgM reactive. However, all 16 serum samples obtained after 3 days of illness from 16 patients contained IgM to B19. Nine different serum samples with B19 antigen were subjected to PCR amplification with each of the three primer sets listed in Table 1 . After amplification, one serum sample from France did not react with primers K6 and K7 and one Richmond isolate did not react with K8 and K9. All the other isolates reacted with each of the three sets of primers (Table  2) .
To determine the feasibility of using PCR in a variety of specimens, partially purified B19 virus was diluted 1:10,000 and added to lymphocytes, urine, and ascitic and pleural fluids. PCR detected B19 DNA in these specimens. Pleural (24) . Besides sensitivity, PCR has other advantages for diagnostic laboratories over dot blot hybridization. First, a radiolabeled probe would be unnecessary for many serum samples. B19 infections typically produce high titers of virus in sera, especially during aplastic crisis (6) . In this study, 20 serum samples were positive after ethidium bromide staining, and only 4 serum samples required a radiolabeled probe for detection of amplified B19 DNA. Second, the procedure is complete within 8 h. Third, an automated thermocycler for temperature shifts eliminates personnel time and allows multiple specimens to be tested simultaneously.
PCR has two disadvantages. First, specimen contamination occurs easily. Avoiding contamination requires meticulous care in the handling and transfer of specimens. Second, not all sets of probes will detect all isolates. Of nine isolates tested against all three sets of probes, two isolates each failed to react with one set of probes. However, we did find one set of probes that reacted with all of the isolates. This was expected, because epidemiologically different isolates of B19 have variations in restriction enzyme sites, indicating genetic heterogeneity (B. J. Cohen, personal communication).
PCR is specific and sensitive for detecting B19 viremia but should be used with IgM detection for the diagnosis of B19 infection, especially when only a single specimen is tested. Using dot blot hybridization to detect virus, Anderson et al. showed that B19 viremia precedes the appearance of B19-specific IgM and that IgM persists for weeks after viremia has cleared (5). Thus, patient sera obtained early in infection may lack IgM to B19 but be PCR positive. Later during infection, sera may be PCR negative but contain IgM. This agrees with our observations. Four serum samples obtained early in infection were PCR positive and lacked IgM and IgG. Five serum samples obtained late in infection were IgM and IgG positive and PCR negative.
Finally, we and others have recently observed immunocompromised patients with chronic B19 infections (15, 16; Koch and Adler, in press). These chronic infections occur because of the inability of these patients to produce adequate levels of IgG or IgM antibodies to B19; antigen or DNA detection is required for diagnosis. For these immunocompromised patients PCR, because of its excellent sensitivity and specificity, is likely to be the most useful of the currently available diagnostic tests.
